chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Dyspnoea, Headache, Malaise, Myalgia
Clinical narrative: Shortness of breath; Body aches; Pain; Headache; Nausea; Muscle pain; injection site pain; fever; feeling unwell; swelling of throat; weakness.; This is a spontaneous report from a contactable consumer.  A male patient of 62 years age received BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE LOT number UNKNOWN) On 21Mar2021 16:30 via an unspecified route of administration, on the left arm as a single first dose (at the age of 62 years) for Covid-19 immunization. Patients medical history reports bronchitis, COPD, asthma and oral cancer from 8/01 and operation/recovery/radiation till 11/01. The patient reports allergy to penicillin, nuts. Prior to vaccination patient has was not diagnosed with COVID-19. Since vaccination patient has not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received doxycycline(UNKNOWN MANUFACTURER), metronidazole(UNKNOWN MANUFACTURER), guaifenesin(UNKNOWN MANUFACTURER), aspirin(UNKNOWN MANUFACTURER) within 2 weeks of vaccination. On 22Mar2021 patient reports to have shortness of breath, body aches & pain, headache, nausea/threw-up, muscle pain, injection site pain, fever, feeling unwell, swelling of throat, weakness. The patient also reports to have a compromised immune system due to oral cancer. No treatment was taken as a result of the events  shortness of breath, body aches & pain, headache, nausea/threw-up, muscle pain, injection site pain, fever, feeling unwell, swelling of throat, weakness. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care.  The clinical outcome of shortness of breath, body aches & pain, headache, nausea/threw-up, muscle pain, injection site pain, fever, feeling unwell, swelling of throat, weakness was recovering.   No follow-up attempts are possible; information about lot number cannot be obtained.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Pain, Pharyngeal swelling, Pyrexia, Vaccination site pain
Clinical narrative: Shortness of breath; Body aches; Pain; Headache; Nausea; Muscle pain; injection site pain; fever; feeling unwell; swelling of throat; weakness.; This is a spontaneous report from a contactable consumer.  A male patient of 62 years age received BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE LOT number UNKNOWN) On 21Mar2021 16:30 via an unspecified route of administration, on the left arm as a single first dose (at the age of 62 years) for Covid-19 immunization. Patients medical history reports bronchitis, COPD, asthma and oral cancer from 8/01 and operation/recovery/radiation till 11/01. The patient reports allergy to penicillin, nuts. Prior to vaccination patient has was not diagnosed with COVID-19. Since vaccination patient has not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received doxycycline(UNKNOWN MANUFACTURER), metronidazole(UNKNOWN MANUFACTURER), guaifenesin(UNKNOWN MANUFACTURER), aspirin(UNKNOWN MANUFACTURER) within 2 weeks of vaccination. On 22Mar2021 patient reports to have shortness of breath, body aches & pain, headache, nausea/threw-up, muscle pain, injection site pain, fever, feeling unwell, swelling of throat, weakness. The patient also reports to have a compromised immune system due to oral cancer. No treatment was taken as a result of the events  shortness of breath, body aches & pain, headache, nausea/threw-up, muscle pain, injection site pain, fever, feeling unwell, swelling of throat, weakness. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care.  The clinical outcome of shortness of breath, body aches & pain, headache, nausea/threw-up, muscle pain, injection site pain, fever, feeling unwell, swelling of throat, weakness was recovering.   No follow-up attempts are possible; information about lot number cannot be obtained.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Dry mouth, Dysphagia, Dyspnoea, Heart rate
Clinical narrative: felt a lump in the back throat; difficult to swallow; breathing difficulty; panic attack; mouth became increasingly dry; throat becoming more sore; hot flashes to my face; urgency to use the restroom; swollen  throat; This is a spontaneous report received from a contactable consumer, the patient. A 34-year-old non pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6208) via an unspecified route in the right arm on 18Mar2021 at 07:15 (at the age of 34-years-old), as a single dose for COVID-19 immunisation. Medical history included Benign tumour removed schwanoma (3.5lbs).  The patient had a history of allergy to penicillin, latex (nurse used latex free gloves) and normally that just cause a rash. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received macrogol 3350 (MIRALAX) for unknown indication within two weeks of vaccination. On 18Mar2021 at 07:15, the patient was very excited to get vaccine, within seconds of the shot she felt a lump in the back of her throat and difficult to swallow but was able to breathe and swallow. The patient also stated that throat was still very sore but she could breathe and swallow easily. The patient went back to paramedics in observation they told her she was having a panic attack which she never had before. The patient went back to her seat for a few minutes but her mouth became increasingly dry with difficulty to swallow and throat became sorer along with a few hot flashes to face, and felt an urgency to use the restroom. Nurse wheeled her out to bathroom and then took her to paramedics. They took her blood pressure and heart rate and told that she had a panic attack. The patient was not nervous about getting it so she did not know why that would be. Her throat stayed sore and swollen for about 48 hours. The patient had taken Miralax 3 days prior with no reactions. Doctor still wanted her to get second vaccine but she was scared of anaphylaxis. The patient did not receive treatment for the reported events. Adverse events resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of felt a lump in the back throat, difficult to swallow, breathing difficulty, panic attack, mouth became increasingly dry, throat became more sore, hot flashes to my face, urgency to use the restroom and swollen throat were recovering at the time of this report. No follow-up attempts are needed. No further information is expected.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Hot flush, Hypertonic bladder, Oropharyngeal pain, Panic attack, Pharyngeal swelling
Clinical narrative: felt a lump in the back throat; difficult to swallow; breathing difficulty; panic attack; mouth became increasingly dry; throat becoming more sore; hot flashes to my face; urgency to use the restroom; swollen  throat; This is a spontaneous report received from a contactable consumer, the patient. A 34-year-old non pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6208) via an unspecified route in the right arm on 18Mar2021 at 07:15 (at the age of 34-years-old), as a single dose for COVID-19 immunisation. Medical history included Benign tumour removed schwanoma (3.5lbs).  The patient had a history of allergy to penicillin, latex (nurse used latex free gloves) and normally that just cause a rash. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received macrogol 3350 (MIRALAX) for unknown indication within two weeks of vaccination. On 18Mar2021 at 07:15, the patient was very excited to get vaccine, within seconds of the shot she felt a lump in the back of her throat and difficult to swallow but was able to breathe and swallow. The patient also stated that throat was still very sore but she could breathe and swallow easily. The patient went back to paramedics in observation they told her she was having a panic attack which she never had before. The patient went back to her seat for a few minutes but her mouth became increasingly dry with difficulty to swallow and throat became sorer along with a few hot flashes to face, and felt an urgency to use the restroom. Nurse wheeled her out to bathroom and then took her to paramedics. They took her blood pressure and heart rate and told that she had a panic attack. The patient was not nervous about getting it so she did not know why that would be. Her throat stayed sore and swollen for about 48 hours. The patient had taken Miralax 3 days prior with no reactions. Doctor still wanted her to get second vaccine but she was scared of anaphylaxis. The patient did not receive treatment for the reported events. Adverse events resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of felt a lump in the back throat, difficult to swallow, breathing difficulty, panic attack, mouth became increasingly dry, throat became more sore, hot flashes to my face, urgency to use the restroom and swollen throat were recovering at the time of this report. No follow-up attempts are needed. No further information is expected.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Sensation of foreign body
Clinical narrative: felt a lump in the back throat; difficult to swallow; breathing difficulty; panic attack; mouth became increasingly dry; throat becoming more sore; hot flashes to my face; urgency to use the restroom; swollen  throat; This is a spontaneous report received from a contactable consumer, the patient. A 34-year-old non pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6208) via an unspecified route in the right arm on 18Mar2021 at 07:15 (at the age of 34-years-old), as a single dose for COVID-19 immunisation. Medical history included Benign tumour removed schwanoma (3.5lbs).  The patient had a history of allergy to penicillin, latex (nurse used latex free gloves) and normally that just cause a rash. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received macrogol 3350 (MIRALAX) for unknown indication within two weeks of vaccination. On 18Mar2021 at 07:15, the patient was very excited to get vaccine, within seconds of the shot she felt a lump in the back of her throat and difficult to swallow but was able to breathe and swallow. The patient also stated that throat was still very sore but she could breathe and swallow easily. The patient went back to paramedics in observation they told her she was having a panic attack which she never had before. The patient went back to her seat for a few minutes but her mouth became increasingly dry with difficulty to swallow and throat became sorer along with a few hot flashes to face, and felt an urgency to use the restroom. Nurse wheeled her out to bathroom and then took her to paramedics. They took her blood pressure and heart rate and told that she had a panic attack. The patient was not nervous about getting it so she did not know why that would be. Her throat stayed sore and swollen for about 48 hours. The patient had taken Miralax 3 days prior with no reactions. Doctor still wanted her to get second vaccine but she was scared of anaphylaxis. The patient did not receive treatment for the reported events. Adverse events resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of felt a lump in the back throat, difficult to swallow, breathing difficulty, panic attack, mouth became increasingly dry, throat became more sore, hot flashes to my face, urgency to use the restroom and swollen throat were recovering at the time of this report. No follow-up attempts are needed. No further information is expected.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Peripheral swelling
Clinical narrative: Large, golf ball sized swelling in my left arm pit.; This is a spontaneous report received from a contactable consumer, the patient. A 56-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER2613) via unspecified route of administration in the left arm on 22Mar2021 at 14:00 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. The patient had medical history of COVID-19 prior vaccination. The patient had not tested for COVID-19 since the vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient had no any known allergies. Concomitant medications included atorvastatin (MANUFACTURER UNKNOWN), clopidogrel (MANUFACTURER UNKNOWN), cefadroxil (MANUFACTURER UNKNOWN) and aspirin (MANUFACTURER UNKNOWN); all started on unknown date for unknown indication. On 22Mar2021 at 01:00, the patient experienced large, golf ball sized swelling in his left arm pit (swelling armpit). The patient did not receive any treatment for the adverse event. The adverse event did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The clinical outcome of the event swelling armpit was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Malaise
Clinical narrative: Wound up being in bed for most of that day; This is a spontaneous report received from a contactable consumer. A adult male patient received unknown dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot number was not reported), Solution for injection, via an unspecified route of administration on 22Mar2021 as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. It was unknown if the patient received any other vaccines within 4 weeks prior to the COVID vaccine. It was unknown if the patient was diagnosed with COVID-19 prior to vaccination and if he was tested for covid-19 since vaccination. On 22Mar2021, the patient wound up being in bed for most of that day. It was unknown if patient received any treatment due to adverse events. The event was recovered on an unspecified date in Mar2021.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Breast tenderness, Lymphadenopathy
Clinical narrative: Armpits and sides painful hurting; tenderness in breast; swollen lymph nodes; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: en6202), via an unspecified route of administration in the right arm on 26Feb2021 at 18:30 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history reported. The patient did not have any allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 06Mar2021 at 01:00, the patient's armpits and sides were painful and hurting. The patient had tenderness in breast and the patient guessed that it might be swollen lymph nodes. The adverse events did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events armpits and sides painful hurting, tenderness in breast and swollen lymph nodes. The clinical outcomes of the events armpits and sides painful hurting, tenderness in breast and swollen lymph nodes were not recovered at the time of the report.   No follow-up attempts are needed. No further information is expected.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash macular
Clinical narrative: thighs started itching and getting blotchy; Thighs started itching; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old female patient received her first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6199), via an unspecified route of administration on 09Mar2021 at 18:00 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medication included progesterone 200 mg (MANUFACTURER UNKNOWN) for unknown indication from an unknown date. The patient previously received oxycodone; paracetamol (PERCOCET) and experienced drug allergy. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 22Mar2021 at 11:30, two weeks after the vaccination, the patient was sitting in the sun with her legs uncovered. Her thighs started itching and got blotchy. Her calves did not experience the same. She had not tried sunning her torso or arms yet. On 24Mar2021 (reported as this morning), she went out again and experienced same thing. She had photos of her legs during and after she came back inside. The adverse events did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events itching and blotchy. The clinical outcomes of the events itching and blotchy were recovered with sequelae (reported as recovered with lasting effects) on an unknown date in Mar2021.   No follow-up attempts are needed. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Musculoskeletal discomfort
Clinical narrative: tightness and discomfort in lungs/chest. from front of chest and feeling it in my back also; discomfort inlungs/chest. from front of chest andfeeling it in my back also; This is a spontaneous report received from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received her first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6207) via an unspecified route of administration in the left arm on 12Mar2021 at 16:00 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Medical history included chronic obstructive pulmonary disease (COPD). The patient had a history of allergy to nonsteroidal anti-inflammatory drugs (NSAIDs). Concomitant medication included trazodone (MANUFACTURER UNKNOWN) 50mg once daily at night for an unknown indication received within two weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On an unknown date in Mar2021 about day 9 after the vaccination, the patient had experienced tightness and discomfort in lungs/chest, from front of chest and felt in her back also. Adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for events. The clinical outcome of the events tightness and discomfort in lungs/chest, from front of chest and felt in her back also was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia, Vision blurred
Clinical narrative: About 3 hours after the vaccine I was driving and suddenly my vision got blurry; felt tingling in my face; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the right arm on 23Mar2021 at 09:30 hrs (at the age of 61-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history reported. The patient did not have an allergy to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. Concomitant medications included B-12 complex (cyanocobalamin) (MANUFACTURER UNKNOWN), CoQ10 (ubidecarenone) (MANUFACTURER UNKNOWN), multi-vitamins (MANUFACTURER UNKNOWN), vitamin D3 (cholecalciferol) (MANUFACTURER UNKNOWN), turmeric (MANUFACTURER UNKNOWN) all for unknown indications and from an unknown date. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 23Mar2021 at 13:30 (about 3 hours post-vaccination), the patient was driving and suddenly had blurry vision and felt tingling in the face. The tingling sensation lasted 2 seconds for about 2 to 3 hours. The tingling sensation reduced every hour. The event did not result in a doctor or other healthcare professional office/clinic visit, and the emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events tingling in the face and vision blurred was recovered on an unknown day in Mar2021.   Information about lot/batch number cannot be obtained. No further information is expected.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Pain, Throat tightness
Clinical narrative: tightness in her throat; shortness of breath; her right arm was aching and went up into her shoulder and neck; This is a spontaneous report from a contactable consumer or other non hcp. A 79-year-old female patient received bnt162b2 (BNT162B2, Batch/Lot number was not reported) via an unspecified route of administration in the left arm on 01Mar2021 as dose 1, single for covid-19 immunisation. The patient's medical history included food allergy allergies to soy, drug hypersensitivity, allergies to antibiotics, drug hypersensitivity from an unknown date and unknown if ongoing allergies to blood pressure medications and the patient had lung problems, she does not have COPD, but she has bacteria in her lungs called MRSA. The patient's concomitant medications were not reported. On an unspecified date, the patient experienced tightness in her throat, shortness of breath, her right arm was aching and went up into her shoulder and neck. She checked her oxygen levels, and they were fine, so she did not go to the emergency room. The patient was due for her second dose next Monday. Therapeutic measures were taken as a result of tightness in her throat, shortness of breath, her right arm was aching and went up into her shoulder and neck. The patient took a breathing treatment and it helped some and had Benadryl and had going into deep sleeps at times. The outcome of the events was unknown  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Erythema, Fatigue, Headache, Injection site pain
Clinical narrative: Injection site pain; Tiredness; chills; headache; injection site swelling; redness; nausea; This is a spontaneous report from a contactable consumer, the patient. A 73-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6208), via an unspecified route of administration in the right arm on 18Mar2021 at 14:00 (at the age of 73-years-old) as a single dose for COVID-19 immunisation. Medical history included multiple sclerosis, lung disease, vitamin B deficiency and coronary artery disease. The patient was allergic to promethazine (PHENERGAN), prochlorperazine (COMPAZINE), metoclopramide (REGLAN) and tetanus toxoid (TETANUS). Prior to vaccination, the patient was not diagnosed with COVID-19. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EM9810), via an unspecified route of administration in the right arm on 25Feb2021 at 14:00 (at the age of 73-years-old) as single dose for COVID-19 immunisation. The patient received other medicines (unspecified) within two weeks prior to the COVID-19 vaccine. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient was not tested for COVID-19. On 19Mar2021 at 16:00 the patient experienced injection site pain, tiredness, chills, headache, injection site swelling, redness and nausea. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events injection site pain, tiredness, chills, headache, injection site swelling, redness and nausea were not recovered at the time of reporting.   No follow-up attempts possible. No further information expected.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site swelling, Nausea
Clinical narrative: Injection site pain; Tiredness; chills; headache; injection site swelling; redness; nausea; This is a spontaneous report from a contactable consumer, the patient. A 73-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6208), via an unspecified route of administration in the right arm on 18Mar2021 at 14:00 (at the age of 73-years-old) as a single dose for COVID-19 immunisation. Medical history included multiple sclerosis, lung disease, vitamin B deficiency and coronary artery disease. The patient was allergic to promethazine (PHENERGAN), prochlorperazine (COMPAZINE), metoclopramide (REGLAN) and tetanus toxoid (TETANUS). Prior to vaccination, the patient was not diagnosed with COVID-19. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EM9810), via an unspecified route of administration in the right arm on 25Feb2021 at 14:00 (at the age of 73-years-old) as single dose for COVID-19 immunisation. The patient received other medicines (unspecified) within two weeks prior to the COVID-19 vaccine. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient was not tested for COVID-19. On 19Mar2021 at 16:00 the patient experienced injection site pain, tiredness, chills, headache, injection site swelling, redness and nausea. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events injection site pain, tiredness, chills, headache, injection site swelling, redness and nausea were not recovered at the time of reporting.   No follow-up attempts possible. No further information expected.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Peripheral swelling, Pruritus
Clinical narrative: slight itching and small bump onright arm.; small bump on right arm; discomfort with small knot in lower right abdomen; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA vaccine; Lot number; En6208) via an unspecified route of administration in the right arm on 20Mar2021 at 15:00 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure and type 2 diabetes. The patient had a history of allergy to shellfish and PAC (perennial allergic conjunctivitis). Concomitant medications received within two weeks of vaccination included valsartan (MANUFACTURER UNKNOWN) and metformin hydrochloride (MANUFACTURER UNKNOWN) for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. On 24Mar2021 at 16:00, the patient had experienced slight itching and small bump on right arm. She had noticed discomfort with a small knot in lower right abdomen on Wednesday. Adverse event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events slight itching and small bump on right arm, discomfort with small knot in lower right abdomen were not resolved at the time of report. No follow-up attempts are needed. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Lymph node pain, Lymphadenopathy
Clinical narrative: Tenderness from swollen lymphnodes in arm pit area; Swollen lymph nodes in armpit area; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL3247), via an unspecified route of administration in the left arm on 22Mar2021 at 10:00 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to penicillin. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medication included omeprazole (PRILOSEC) OTC as directed on box for an unknown indication from an unknown date. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL3247), via an unspecified route of administration in the left arm on 01Mar2021 at 10:00 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. The patient previously received sulfamethoxazole (MANUFACTURER UNKNOWN) and experienced drug allergy. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 24Mar2021, the patient experienced tenderness from swollen lymph nodes in armpit area. The adverse events did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events lymph node tenderness and axillary lymph nodes enlarged. The clinical outcomes of the events lymph node tenderness and axillary lymph nodes enlarged were not recovered at the time of the report.   No follow-up attempts are needed. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Dyspepsia, Fatigue, Gastric dilatation, Headache
Clinical narrative: Stomach indigestion; Nausea; headache; diarrhea; Stomach distended; exhaustion; The morning after vaccine it hurt toraise my arm; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA Vaccine; Lot number: EN6205), administered in left arm on 09Mar2021 (at the age of 58-year-old) as a single dose for COVID-19 immunisation. The patient was allergic to penicillin, imodium, shellfish and bees stings. Concomitant medications included phentermine (MANUFACTURER UNKNOWN), Fexofenadine hydrochloride (ALLEGRA), Diphenhydramine hydrochloride (BENADRYL). The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. Prior to vaccination, patient was not tested for COVID-19. Since the vaccination, patient has not tested positive for COVID-19. On 10Mar2021 at 07:00, after the vaccination, the patient experienced pain in arm, around 14:00 he experienced exhaustion. On 11Mar2021, the patient experienced stomach indigestion, nausea, headache, diarrhea and stomach distended. It was reported that, the morning after vaccine it hurt to raise her arm. Around 14:00 PM she was very exhausted all she wanted to do was sleep. The next four days she had terrible stomach indigestion, nausea, headache and diarrhea which probably woke her up out of asleep. It felt like a volcano irrupting in her stomach and stomach was very distended. The patient took tumbs which would not help, but pepsid did help for the most part. The headache was constant, but at times it would go away and then come back. The patient only took Aleve once or twice for headache. Further it was reported that, the patient really did not feel good until the 17Mar2021.The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events pain in arm, exhaustion, stomach indigestion, nausea, headache, diarrhea and stomach distended were recovered on 17Mar2021.   No follow-up attempts are needed. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain in extremity
Clinical narrative: Stomach indigestion; Nausea; headache; diarrhea; Stomach distended; exhaustion; The morning after vaccine it hurt toraise my arm; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA Vaccine; Lot number: EN6205), administered in left arm on 09Mar2021 (at the age of 58-year-old) as a single dose for COVID-19 immunisation. The patient was allergic to penicillin, imodium, shellfish and bees stings. Concomitant medications included phentermine (MANUFACTURER UNKNOWN), Fexofenadine hydrochloride (ALLEGRA), Diphenhydramine hydrochloride (BENADRYL). The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. Prior to vaccination, patient was not tested for COVID-19. Since the vaccination, patient has not tested positive for COVID-19. On 10Mar2021 at 07:00, after the vaccination, the patient experienced pain in arm, around 14:00 he experienced exhaustion. On 11Mar2021, the patient experienced stomach indigestion, nausea, headache, diarrhea and stomach distended. It was reported that, the morning after vaccine it hurt to raise her arm. Around 14:00 PM she was very exhausted all she wanted to do was sleep. The next four days she had terrible stomach indigestion, nausea, headache and diarrhea which probably woke her up out of asleep. It felt like a volcano irrupting in her stomach and stomach was very distended. The patient took tumbs which would not help, but pepsid did help for the most part. The headache was constant, but at times it would go away and then come back. The patient only took Aleve once or twice for headache. Further it was reported that, the patient really did not feel good until the 17Mar2021.The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events pain in arm, exhaustion, stomach indigestion, nausea, headache, diarrhea and stomach distended were recovered on 17Mar2021.   No follow-up attempts are needed. No further information is expected.
Age: 33.0
Sex: U
Vaccine: COVID19
Symptoms: Nausea, Vomiting
Clinical narrative: nausea; vomiting; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old patient of unknown gender received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in left arm on 23Mar2021 at 08:45 (at the age of 33-year-old), as a single dose for COVID-19 immunisation. Medical history was reported as NA. The patient did not have allergies to medications, food, or other products. Concomitant medications were reported as no. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since having the vaccine, the patient had not been tested for COVID-19. On 25Mar2021 at 00:15, the patient experienced nausea, vomiting. The clinical outcome of the events nausea and vomiting was unknown.   No follow-up attempts are needed. Information about lot/ batch number cannot be obtained.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Headache, Malaise
Clinical narrative: Injection site pain; severe muscle pain; joint pain; fever; chills; nausea; feeling unwell; headache; fatigue; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA; Lot Number: EL3247) via an unspecified route of administration in the right arm on 22Mar2021 at 11:00 (at the age of 66-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as no. The patient did not have a history of allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA; Lot Number: EL3247) via an unspecified route of administration on 02Mar2021 (at the age of 66-years-old) as a single dose for COVID-19 immunisation. Concomitant medications included ibuprofen (ADVIL), vitamin D (MANUFACTURER UNKNOWN), vitamin B (MANUFACTURER UNKNOWN), calcium (MANUFACTURER UNKNOWN), magnesium (MANUFACTURER UNKNOWN) and collagen (MANUFACTURER UNKNOWN); all for unknown indication. Since the vaccination, patient had not been tested for COVID-19. On 22Mar2021 at 18:00, the patient had experienced injection site pain, severe muscle pain, joint pain, fever, chills, nausea, feeling unwell, headache and fatigue. Adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the events injection site pain, severe muscle pain, joint pain, fever, chills, nausea, feeling unwell, headache and fatigue was resolved on an unknown date in Mar2021. No follow-up attempts are needed. No further information is expected.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Pyrexia, Vaccination site pain
Clinical narrative: Injection site pain; severe muscle pain; joint pain; fever; chills; nausea; feeling unwell; headache; fatigue; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA; Lot Number: EL3247) via an unspecified route of administration in the right arm on 22Mar2021 at 11:00 (at the age of 66-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as no. The patient did not have a history of allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA; Lot Number: EL3247) via an unspecified route of administration on 02Mar2021 (at the age of 66-years-old) as a single dose for COVID-19 immunisation. Concomitant medications included ibuprofen (ADVIL), vitamin D (MANUFACTURER UNKNOWN), vitamin B (MANUFACTURER UNKNOWN), calcium (MANUFACTURER UNKNOWN), magnesium (MANUFACTURER UNKNOWN) and collagen (MANUFACTURER UNKNOWN); all for unknown indication. Since the vaccination, patient had not been tested for COVID-19. On 22Mar2021 at 18:00, the patient had experienced injection site pain, severe muscle pain, joint pain, fever, chills, nausea, feeling unwell, headache and fatigue. Adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the events injection site pain, severe muscle pain, joint pain, fever, chills, nausea, feeling unwell, headache and fatigue was resolved on an unknown date in Mar2021. No follow-up attempts are needed. No further information is expected.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue, Feeling cold, Headache
Clinical narrative: This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non- pregnant female patient received her second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EP7534,), via an unspecified route of administration in the left arm on 23Mar2021 (at the age of 32-years-old) at 09:45 as a single dose for COVID-19 immunisation. Medical history included allergies (unspecified) and herpes simplex virus. The patient had a history of allergy to erythromycin. Concomitant medications included valacyclovir (MANUFACTURER UNKNOWN), ethinylestradiol; norgestimate (SPRINTEC), mometasone furoate (FLONASE), cetirizine hydrochloride (ZYRTEC) for unknown indication from an unspecified date. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EN6198), via an unspecified route of administration in the left arm on 02Mar2021 at 09:30 as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient was not diagnosed with COVID-19 prior to the vaccination. The patient had not been tested for COVID-19 since having the vaccine. On 23Mar201 at 12:00, the patient had experienced sore arm, fever of 100F, fatigue, pounding headache, tiredness and cold during the day. On the same day, the patient also experienced chills and reported that she could not get warm under 5 blankets for the entire night. The patient did not receive any treatment for the reported events. Adverse event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events arm soreness, fever 100F, chills, tiredness/fatigue, headache and could not get warm under 5 blankets for the entire night, cold during the day was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non- pregnant female patient received her second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EP7534,), via an unspecified route of administration in the left arm on 23Mar2021 (at the age of 32-years-old) at 09:45 as a single dose for COVID-19 immunisation. Medical history included allergies (unspecified) and herpes simplex virus. The patient had a history of allergy to erythromycin. Concomitant medications included valacyclovir (MANUFACTURER UNKNOWN), ethinylestradiol; norgestimate (SPRINTEC), mometasone furoate (FLONASE), cetirizine hydrochloride (ZYRTEC) for unknown indication from an unspecified date. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EN6198), via an unspecified route of administration in the left arm on 02Mar2021 at 09:30 as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient was not diagnosed with COVID-19 prior to the vaccination. The patient had not been tested for COVID-19 since having the vaccine. On 23Mar201 at 12:00, the patient had experienced sore arm, fever of 100F, fatigue, pounding headache, tiredness and cold during the day. On the same day, the patient also experienced chills and reported that she could not get warm under 5 blankets for the entire night. The patient did not receive any treatment for the reported events. Adverse event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events arm soreness, fever 100F, chills, tiredness/fatigue, headache and could not get warm under 5 blankets for the entire night, cold during the day was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Pain in extremity, Vertigo
Clinical narrative: Sore arm; fatigue day 2 to 3; dizziness day 2 - current; vertigo day 5 to current; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 18Mar2021 at 14:00 (at the age of 58-years-old), as a single dose for COVID-19 immunisation. Medical history included Peripheral polyneuropathy and allergies to vicodin, tuna, basil and yeast. Concomitant medications included duloxetine (MANUFACTURER UNKNOWN) and pregabalin (MANUFACTURER UNKNOWN), both for unknown indications from unknown dates. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 23Mar2021 at 09:00 the patient experienced sore arm, fatigue on day 2 to 3, dizziness from day 2 to current and vertigo from day 5 to current. Therapeutic measures were taken as a result of sore arm, fatigue, dizziness and vertigo and included treatment with valium meclizine. The events resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the event fatigue was resolved on 24Mar2021 (day 2 to 3) and for events pain in arm, dizziness and vertigo was not resolved at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: Itchy, started within 15 minutes of the injection; This is a spontaneous report from a contactable consumer, the patient. A 67-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 23Mar2021 at 13:15 (at the age of 67-years-old), as a single dose for COVID-19 immunisation. Medical history included hypertension and panic attacks. The patient had a history of allergy to sulfur. The concomitant medications were reported as no. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration on 05Mar2021 at 08:45 (at the age of 67-years-old), as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine and did not receive any other medications within 2 weeks of the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 23Mar2021 at 13:30, the patient felt Itchy and it started within 15 minutes of the injection. No treatment was received for the reported events. The adverse event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event itchy was not recovered at the time of reporting.   Information about lot/batch number cannot be obtained. No further information is expected.